Results 121 to 130 of about 1,973,166 (180)

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. [PDF]

Eur Respir J
Whetstone C, Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K, Killian K, Holt K, Sehmi R, Smith JA, O'Byrne PM, Satia I, Gauvreau GM.   +17 more
europepmc   +1 more source

P2X3-selective mechanism of Gefapixant, a drug candidate for the treatment of refractory chronic cough. [PDF]

Comput Struct Biotechnol J, 2022
Cui WW, Wang SY, Zhang YQ, Wang Y, Fan YZ, Guo CR, Li XH, Lei YT, Wang WH, Yang XN, Hattori M, Li CZ, Wang J, Yu Y.   +13 more
europepmc   +1 more source

Sodium channel blockers as add-on treatment for unexplained refractory chronic cough: a case report and review. [PDF]

Front Med (Lausanne)
Butnariu I, Balan MF, Zaharia DC, Bobocea R, Mitrică IA, Moraru A, Dionisie V, Lăptoiu VI, Antonescu-Ghelmez D, Antonescu F.   +9 more
europepmc   +1 more source

Granulomatosis with Polyangiitis Presenting as Refractory Chronic Cough, Manifesting by Massive Alveolar Haemorrhage - A Rare Case Report. [PDF]

Int Med Case Rep J, 2021
Al Zaidi A, Al Zahrani AM, Alzahrani Z.
europepmc   +1 more source

Clinical impact and healthcare resource utilisation in patients with unexplained or refractory chronic cough: a French national population study. [PDF]

ERJ Open Res
Guilleminault L, Le Moine G, Ruiz F, Ziad A, Goldberg M, Zins M, Roche N.   +6 more
europepmc   +1 more source

A retrospective study to understand the journey and health status of patients with unexplained or refractory chronic cough in the Netherlands. [PDF]

Chron Respir Dis
van den Berg JWK, Edens M, Oedit Doebé AR, van der Velden H, Heezen MR.   +4 more
europepmc   +1 more source

Reply to Rui and Chen: Initial Success: Camlipixant in Refractory Chronic Cough. [PDF]

Am J Respir Crit Care Med
Smith JA.
europepmc   +1 more source

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial. [PDF]

Eur Respir J
Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K, Killian K, Holt K, Sehmi R, Gauvreau GM, Smith JA, O'Byrne PM, Satia I.   +16 more
europepmc   +1 more source

Prevalence and burden of possible refractory chronic cough in four European countries. [PDF]

ERJ Open Res
Domínguez-Ortega J, Virchow JC, Guilleminault L, Antonelli Incalzi R, Beyer AP, Ke X, Ding H, Boggs R.   +7 more
europepmc   +1 more source

Telehealth group behavioural cough-suppression therapy for refractory chronic cough using a rolling enrolment model. [PDF]

ERJ Open Res
Slovarp LJ, Salois JR, Roberts K, Ehli E, Majors M, Rosenleaf M.   +5 more
europepmc   +1 more source